{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:07:52Z","timestamp":1772579272066,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Aeterna Zentaris GmbH, Frankfurt, Germany"},{"name":"Novo Nordisk Inc., Plainsboro, New Jersey, United States"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ghir.2020.101321","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:57:25Z","timestamp":1586948245000},"page":"101321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study"],"prefix":"10.1016","volume":"52","author":[{"given":"Beate","family":"Klaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Ammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky","family":"Kelepouris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlady","family":"Ostrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2020.101321_bb0005","unstructured":"Macrilen [prescribing information]. Trevose, PA: Strongbridge Biopharma Inc; 2018."},{"key":"10.1016\/j.ghir.2020.101321_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1586\/14737159.2014.915746","article-title":"The macimorelin-stimulated growth hormone test for adult growth hormone deficiency diagnosis","volume":"14","author":"Agrawal","year":"2014","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.ghir.2020.101321_bb0015","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1210\/jc.2013-1157","article-title":"Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency","volume":"98","author":"Garcia","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101321_bb0020","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1210\/jc.2018-00665","article-title":"Macimorelin as a diagnostic test for adult GH deficiency","volume":"103","author":"Garcia","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101321_bb0025","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency","volume":"87","author":"Biller","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101321_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/972617","article-title":"Diagnosing growth hormone deficiency in adults","volume":"2012","author":"Glynn","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101321_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2020.101321_bb0040","doi-asserted-by":"crossref","first-page":"RC26","DOI":"10.1007\/BF03345096","article-title":"EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man","volume":"25","author":"Broglio","year":"2002","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2020.101321_bb0045","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/jc.2006-2160","article-title":"Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects","volume":"92","author":"Piccoli","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101321_bb0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0091270008330160","article-title":"Effect of food on the pharmacokinetics and pharmacodynamics of an oral ghrelin agonist (ARD-07) in healthy subjects","volume":"49","author":"MacLean","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ghir.2020.101321_bb0055","series-title":"Parameters for Compartment-Free Pharmacokinetics","author":"Brett","year":"1999"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637420300307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637420300307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:56Z","timestamp":1761087116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637420300307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":11,"alternative-id":["S1096637420300307"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101321","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101321"}}